Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn T Domsic

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
ReplyRobyn T Domsic, Mary Lucas, Svetlana I Nihtyanova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2015
Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic SclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Practical Radiation Oncology|May 4, 2024
The Impact of Radiation Therapy in Patients with Systemic Sclerosis and Head and Neck CancerRachel S Wallwork, Brandi R Page, Fredrick M Wigley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Arthritis Research & Therapy|September 5, 2019
A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcersVivek Nagaraja, Cathie Spino, Erica Bush, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2021
Reply to Andréasson <i>et al.</i>: Multiple Manifestations of Systemic Sclerosis Affect Walk DistanceRoham T Zamanian, Ashley Pinckney, Robyn T Domsic, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 11, 2023
Loss of Protein Kinase D2 Activity Protects Against Bleomycin-Induced Dermal Fibrosis in MiceLiping Chen, Jinjun Zhao, Yapeng Chao, et al.
Clinical and Experimental Rheumatology|August 6, 2013
Treatment of early diffuse systemic sclerosis skin diseaseTracy M Frech, Victoria K Shanmugam, Ami A Shah, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2023
Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease CourseJi Soo Kim, Adrianne Woods, Laura Gutierrez-Alamillo, et al.
Arthritis Care & Research|October 10, 2022
Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short-Form DevelopmentLan Yu, Robyn T Domsic, Lesley-Ann Saketkoo, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
ReplyRobyn T Domsic, Mary Lucas, Svetlana I Nihtyanova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2015
Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic SclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Practical Radiation Oncology|May 4, 2024
The Impact of Radiation Therapy in Patients with Systemic Sclerosis and Head and Neck CancerRachel S Wallwork, Brandi R Page, Fredrick M Wigley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Arthritis Research & Therapy|September 5, 2019
A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcersVivek Nagaraja, Cathie Spino, Erica Bush, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2021
Reply to Andréasson <i>et al.</i>: Multiple Manifestations of Systemic Sclerosis Affect Walk DistanceRoham T Zamanian, Ashley Pinckney, Robyn T Domsic, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 11, 2023
Loss of Protein Kinase D2 Activity Protects Against Bleomycin-Induced Dermal Fibrosis in MiceLiping Chen, Jinjun Zhao, Yapeng Chao, et al.
Clinical and Experimental Rheumatology|August 6, 2013
Treatment of early diffuse systemic sclerosis skin diseaseTracy M Frech, Victoria K Shanmugam, Ami A Shah, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2023
Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease CourseJi Soo Kim, Adrianne Woods, Laura Gutierrez-Alamillo, et al.
Arthritis Care & Research|October 10, 2022
Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short-Form DevelopmentLan Yu, Robyn T Domsic, Lesley-Ann Saketkoo, et al.
Pageof 10